Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-27), Nihon Kohden's 9-Day RSI is 74.28.
The industry rank for Nihon Kohden's 9-Day RSI or its related term are showing as below:
TSE:6849's 9-Day RSI is ranked worse than 73.61% of 864
companies
in the Medical Devices & Instruments industry
Industry Median: 43.115
vs TSE:6849: 74.28
Nihon Kohden (TSE:6849) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Nihon Kohden 9-Day RSI Related Terms
TSE:6849 vs ABT, SYK, MDT: 9-Day RSI Comparison
For the Medical Devices subindustry, Nihon Kohden's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Kohden 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Nihon Kohden's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Kohden (TSE:6849) has a 9-Day RSI of 74.28 as of Jul. 27, 2026. According to the industry distribution chart, Nihon Kohden ranks #636 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 73.6%.
Is Nihon Kohden's 9-Day RSI too high?
Nihon Kohden's current 9-Day RSI is 74.28. The Medical Devices & Instruments industry median 9-Day RSI is 43.12. Nihon Kohden's value of 74.28 is 72.3% above this industry median. Based on the distribution chart, Nihon Kohden ranks #636 out of 864 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nihon Kohden has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nihon Kohden's 9-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nihon Kohden ranks #636 out of 864 companies for 9-Day RSI. This places Nihon Kohden in the lower half of its industry. The industry median 9-Day RSI is 43.12. Nihon Kohden's value of 74.28 is 72.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 43.12, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Kohden's current 9-Day RSI of 74.28 is 72.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 43.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Kohden's current 9-Day RSI is 74.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Kohden stock overvalued right now?
Based on GuruFocus' analysis, Nihon Kohden (TSE:6849) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,162.23, compared to a current price of 円1,600.00 — trading 26% below its estimated fair value. The current 9-Day RSI is 74.28 and 72.3% above the Medical Devices & Instruments industry median of 43.12. Nihon Kohden's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Nihon Kohden (TSE:6849), the current 9-Day RSI is 74.28 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Kohden (TSE:6849) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Kohden stock appears to be undervalued.
The current stock price of 円1,600.00 is trading 26% below its estimated GF Value™ of 円2,162.23.
GuruFocus considers Nihon Kohden to be Modestly Undervalued.
Key valuation signals for TSE:6849:
9-Day RSI: 74.28
GF Value™: 円2,162.23 vs. price of 円1,600.00 (26% below fair value)
Industry Position: 72.3% above the Medical Devices & Instruments median (#636 of 864)
No single metric tells the full story. See the TSE:6849 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
73GF Score
Get the complete analysis for TSE:6849
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6849 has been successfully added to your 
